Nishida Y., Hosomi S., Fujimoto K., Kobayashi Y., Nakata R., Maruyama H., Ominami M., Nadatani Y., Fukunaga S., Otani K., et al. Impact of 5-Aminosalicylic Acid on Ustekinumab in Inflammatory Bowel Disease: A Retrospective Medical Claims Analysis. Inflammatory bowel diseases. 2025
Nishida Y., Hosomi S., Fujimoto K., Kobayashi Y., Nakata R., Maruyama H., Ominami M., Nadatani Y., Fukunaga S., Otani K., et al. Evaluating the effects of 5-aminosalicylic acid on tofacitinib treatment in ulcerative colitis. Journal of gastroenterology and hepatology. 2025. 40. 1. 108-114
Hisaki Y., Sawada A., Kobayashi Y., Nishida Y., Maruyama H., Ominami M., Nadatani Y., Otani K., Fukunaga S., Hosomi S., et al. Epidemiology of Rome IV Fecal Incontinence in Japan: An Internet Survey of 9995 Individuals. Journal of gastroenterology and hepatology. 2024
Nishida Y., Hosomi S., Kobayashi Y., Nakata R., Ominami M., Nadatani Y., Fukunaga S., Otani K., Tanaka F., Kamata N., et al. Gastrointestinal: Severe SARS-CoV-2-related enteritis improved with cyclophosphamide. Journal of gastroenterology and hepatology. 2024. 39. 11. 2243-2244
Fujimoto K., Hosomi S., Kobayashi Y., Nakata R., Nishida Y., Ominami M., Nadatani Y., Fukunaga S., Otani K., Tanaka F., et al. Tuberculosis risk in patients with Crohn's disease on biologics: a retrospective analysis of the Japanese Medical Claims Database. Intestinal research. 2024